Aug 1, 2016 ... GenSpera, Inc. (OTC/QB: GNSZ), a clinical-stage biotechnology company ...
shareholder value,” said Peter E. Grebow, Ph.D., Interim Chairman.
GenSpera unlocks conventional thinking to conceive, design, and develop
curative cancer therapies that are core ... By Craig A. Dionne, Ph.D. | GenSpera,
Learn about working at GenSpera, Inc.. Join LinkedIn today for free. See who you
know at GenSpera, Inc., leverage your professional network, and get hired.
Jun 27, 2012 ... Samuel R. Denmeade,*,; Annastasiah M. Mhaka,; D. Marc Rosen, ... George
Wilding,; Michael A. Carducci,; Craig A. Dionne,; Jesper V. Møller,, ...
Nov 13, 2012 ... The active vs. and inactive conformations of HDAC4 were overlaid using the Ca
... Human HIF-Regulated cDNA Plate Array from Signosis Inc (Sunnyvale .... 2%
O2, without increasing CO2 and decreasing pH, 60% knock down of HDAC4 .....
Kallberg E, Vogl T, Liberg D, Olsson A, Bjork P, Wilkstrom P, et al.
Apr 26, 2016 ... ... (ECs) of a variety of solid tumours types (Liu et al, 1997; Chang et al, 1999a,
..... GenSpera, Inc. provided assistance with preparation of this manuscript. ... [
PubMed]; Deniaud A, Sharaf el dein O, Malillier E, Poncet D, Kroemer ... Gill DL,
Isaacs JT (1994) The role of calcium, pH, and cell proliferation in the ...
Purified G202 for animal studies was provided by GenSpera Inc. PSMA fusion ...
Inc. Arrays were stained for PSMA according to the method of Milowsky et al. with
a .... The role of calcium, pH, and cell proliferation in the programmed (apoptotic)
... Deniaud A, Sharaf el dein O, Malillier E, Poncet D, Kroemer G, Lemaire C, ...
May 5, 2009 ... Rabbit polyclonal anti-AR (N-20), Cyclin D1 (H-295), GADD34 (S-20), .... 2A), and
completion of the process of cellular fragmentation into Annexin V–positive
apoptotic bodies (30, 41, 42). ..... J.T. Isaacs and S.R. Denmeade: financial
interest, Genspera, Inc., and .... Singh P, Mhaka AM, Christensen SB, et al.